Aperiomics, a VentureSouth portfolio company, has added a specific test for coronavirus / COVID-19 to its comprehensive technology for identifying infectious diseases.You can learn more about this in the press release, and the coverage in Technical.ly, Loudoun Times,...
VentureSouth is proud to announce another year of record-setting investment activity. The South Carolina-based firm invested $12.7 million in 28 Southeastern early stage companies in 2019, up from $7 million the previous year, representing an 82% increase in capital...
VentureSouth, one of the top 10 angel investment groups in the United States with nearly 350 members, announces another record-breaking level of investing during the first half of 2019. To the end of June, VentureSouth members and fund investors invested $4.8...
Proud of Aperiomics for being featured on the Today Show this week as part of their #ConsumerConfidential segment. “Virginia-based biotech company Aperiomics says it has technology that could shake up health care and find answers for the millions of people living with...